MiR-126-3p inhibits thyroid cancer cell growth and metastasis, and is associated with aggressive thyroid cancer

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Xiong, Yin ^a   Kotian, Shweta ^a   Zeiger, Martha A ^b   Zhang, Lisa ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126 3P; UNCLASSIFIED DRUG; VASCULOTROPIN; ADAM PROTEIN; ADAM9 PROTEIN, HUMAN; AMINO ACID TRANSPORTER; MEMBRANE PROTEIN; MIRN126 MICRORNA, HUMAN;

ADAM9 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SLC7A5 GENE; THYROID CANCER; THYROID CANCER CELL LINE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR INVASION; TUMOR SPHEROID; TUMOR XENOGRAFT; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; THYROID GLAND; THYROID TUMOR; TUMOR CELL LINE;

ADAM PROTEINS; ADENOCARCINOMA, FOLLICULAR; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MEMBRANE PROTEINS; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84941985345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130496     Document Type: Article

References (51)

1. Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807. doi: 10.1002/cncr.24416 PMID: 19598221
2. Institute NC (2011) Thyroid Cancer, [cited 2011 October 6]. Available: http://wwwcancergov/cancertopics/types/thyroid.
3. Visone R, Croce CM (2009) MiRNAs and cancer. Am J Pathol 174: 1131-1138. doi: 10.2353/ajpath. 2009.080794 PMID: 19264914
4. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269. PMID: 16557279
5. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, et al. (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469. doi: 10.1038/nbt1392 PMID: 18362881
6. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, et al. (2007) Specific micro- RNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595. PMID: 17563749
7. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102: 19075-19080. PMID: 16365291
8. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C (2006) A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91: 3584-3591. PMID: 16822819
9. Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, et al. (2011) Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. Ann Surg Oncol 18: 3443-3452. doi: 10.1245/s10434-011-1766-4 PMID: 21553140
10. Kitano M, Rahbari R, Patterson EE, Steinberg SM, Prasad NB, Wang Y, et al. (2012) Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 22: 285-291. doi: 10.1089/thy.2011.0313 PMID: 22304369
11. Zhang L, Gaskin K, Yu Z, Xiong Y, Merino M, Kebebew E. (2013) An in vivo Mouse Model of Human Thyroid Cancer Metastasis. Thyroid.
12. Xiong Y, Zhang L, Holloway AK, Wu X, Su L, Kebebew E. (2011) MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer. PLoS One 6: e24717. doi: 10.1371/journal.pone.0024717 PMID: 21998631
13. Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, et al. (2013) miR-126&126∗ restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 8: e56824. doi: 10.1371/journal.pone.0056824 PMID: 23437250
14. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, et al. (2012) MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 10: 3-10. doi: 10. 1158/1541-7786.MCR-11-0272 PMID: 22064652
15. Jia AY, Castillo-Martin M, Bonal DM, Sanchez-CarbayoM, Silva JM, Cordon-Cardo C, et al. (2014)Micro- RNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. Br J Cancer 110: 2945-2954. doi: 10.1038/bjc.2014.245 PMID: 24823697
16. Miko E, Margitai Z, Czimmerer Z, Varkonyi I, Dezso B, Lányi A, et al. (2011) miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett 585: 1191-1196. doi: 10.1016/j. febslet.2011.03.039 PMID: 21439283
17. Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, et al. (2014) MiR-126-3p Suppresses Tumor Metastasis and Angiogenesis of Hepatocellular Carcinoma by Targeting LRP6 and PIK3R2. J Transl Med 12: 259. doi: 10.1186/s12967-014-0259-1 PMID: 25240815
18. Liu B, Peng XC, Zheng XL, Wang J, Qin YW (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66: 169-175. doi: 10.1016/j. lungcan.2009.01.010 PMID: 19223090
19. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, et al. (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107: 700-706. doi: 10.1038/bjc.2012.330 PMID: 22836510
20. Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, et al. (2013) Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep 30: 1976-1984. doi: 10. 3892/or.2013.2633 PMID: 23900443
21. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731. doi: 10.1016/j.bbrc.2008.12.098 PMID: 19116145
22. Li XM, Wang AM, Zhang J, Yi H (2011) Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 28: 1054-1057. doi: 10.1007/s12032-010-9637-6 PMID: 20680522
23. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557. doi: 10.1371/journal.pone.0002557 PMID: 18596939
24. Miko E, Czimmerer Z, Csanky E, Boros G, Buslig J, Dezso B, et al. (2009) Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 35: 646-664. doi: 10.3109/01902140902822312 PMID: 19895320
25. Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ, et al. (2008) The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140. doi: 10.1016/j.bbrc.2008.09.089 PMID: 18834857
26. Feng RH, Chen XH, Yu YY, Su LP, Yu BQ, Li J, et al. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63. doi: 10.1016/j.canlet.2010.06.004 PMID: 20619534
27. Guo CG, Sah JF, Beard L, Willson JKV, Markowitz SD, Guda K. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes & Cancer 47: 939-946.
28. Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, et al. (2012) MiR-126 Acts as a Tumor Suppressor in Pancreatic Cancer Cells via the Regulation of ADAM9. Molecular Cancer Research 10: 3-10. doi: 10.1158/1541-7786.MCR-11-0272 PMID: 22064652
29. Kinne A, Schulein R, Krause G (2011) Primary and secondary thyroid hormone transporters. Thyroid Res 4 Suppl 1: S7. doi: 10.1186/1756-6614-4-S1-S7 PMID: 21835054
30. Ochiai H, Morishita T, Onda K, Sugiyama H, Maruo T (2012) Canine Lat1: molecular structure, distribution and its expression in cancer samples. J Vet Med Sci 74: 917-922. PMID: 22322188
31. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514: 291-302. PMID: 11557028
32. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. (2009) CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol 16: 3473-3481. doi: 10.1245/s10434-009-0685-0 PMID: 19777189
33. Nakanishi K, Ogata S, Matsuo H, Kanai Y, Endou H, Hiroi S, et al. (2007) Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Virchows Arch 451: 681-690. PMID: 17622555
34. Sakata T, Ferdous G, Tsuruta T, Satoh T, Baba S, Muto T, et al. (2009) L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int 59: 7-18. doi: 10.1111/j. 1440-1827.2008.02319.x PMID: 19121087
35. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. (2015) Proteomics. Tissue-based map of the human proteome. Science 347: 1260419. doi: 10.1126/science.1260419 PMID: 25613900
36. Oda K, Hosoda N, Endo H, Saito K, Tsujihara K, Yamamura M, et al. (2010) L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci 101: 173-179. doi: 10.1111/j.1349-7006.2009.01386.x PMID: 19900191
37. Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, Nakanishi T. (2010) Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Biochem Pharmacol 80: 811-818. doi: 10.1016/j.bcp.2010.05.021 PMID: 20510678
38. Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, et al. (2006) L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119: 484-492. PMID: 16496379
39. Shennan DB, Thomson J (2008) Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. Oncol Rep 20: 885-889. PMID: 18813831
40. Peduto L (2009) ADAM9 as a potential target molecule in cancer. Curr Pharm Des 15: 2282-2287. PMID: 19601830
41. Weskamp G, Cai H, Brodie TA, Higashyama S, Manova K, Ludwig T, et al. (2002) Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol Cell Biol 22: 1537-1544. PMID: 11839819
42. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, et al. (2003) Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 105: 754-761. PMID: 12767059
43. Zigrino P, Mauch C, Fox JW, Nischt R (2005) Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 116: 853-859. PMID: 15856464
44. Tannapfel A, Anhalt K, Hausermann P, Sommerer F, Benicke M, Uhlmann D, et al. (2003) Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201: 238-249. PMID: 14517841
45. Yamada D, Ohuchida K, Mizumoto K, Ohhashi S, Yu J, Egami T, et al. (2007) Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. Anticancer Res 27: 793-799. PMID: 17465204
46. Fritzsche FR, Wassermann K, Jung M, Tolle A, Kristiansen I, Lein M, et al. (2008) ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8: 179. doi: 10. 1186/1471-2407-8-179 PMID: 18582378
47. Fritzsche FR, Jung M, Tolle A, Wild P, Hartmann A, Wassermann K, et al. (2008) ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol 54: 1097-1106. PMID: 18061337
48. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, et al. (2004) Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 64: 4190-4196. PMID: 15205330
49. Hirao T, Nanba D, Tanaka M, Ishiguro H, Kinugasa Y, Doki Y, et al. (2006) Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells. Exp Cell Res 312: 331-339. PMID: 16336960
50. Herrero-Gonzalez S, Di Cristofano A (2011) New routes to old places: PIK3R1 and PIK3R2 join PIK3CA and PTEN as endometrial cancer genes. Cancer Discov 1: 106-107. doi: 10.1158/2159-8290.CD-11-0116 PMID: 22586352
51. Sun X, Wang ZM, Song Y, Tai XH, Ji WY, Gu H. (2014) MicroRNA-126 modulates the tumor microenvironment by targeting calmodulin-regulated spectrin-associated protein 1 (Camsap1). Int J Oncol 44: 1678-1684. doi: 10.3892/ijo.2014.2321 PMID: 24603804